Metadon

Methadone, the active ingredient in Metadon, is a synthetic opioid presented as an oral tablet for oral use. It is used to treat opioid dependence and manage chronic pain in adult patients.

GNH USA supplies Metadon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metadon (methadone) is employed in the management of opioid‑related conditions and chronic pain.

- Opioid dependence: reduces withdrawal symptoms and supports maintenance therapy. - Chronic pain: provides long‑acting analgesia for severe, persistent pain. - Opioid detoxification: facilitates supervised tapering during withdrawal programs.

Metadon may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Cardiac arrhythmia: irregular heart rhythm, including QT prolongation. - Severe hypotension: marked drop in blood pressure.

When prescribing Metadon, clinicians should observe several safety considerations.

- Assess patient history: evaluate prior opioid use, respiratory disorders, and cardiac conditions. - Monitor dosing: adjust gradually and observe for signs of over‑sedation. - Pregnancy and lactation: use only if benefits outweigh risks; category C. - Concomitant CNS depressants: avoid or use with caution due to additive respiratory effects. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Methadone interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - MAO inhibitors: may precipitate severe hypotension or serotonin syndrome. - QT‑prolonging agents: increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Antiretrovirals (e.g., protease inhibitors): can alter methadone plasma levels. - Rifampin and other enzyme inducers: may reduce methadone effectiveness. - SSRIs and SNRIs: may enhance serotonergic effects, requiring monitoring.